Ramdas S, Painho T, Vanegas M, Famili D, Lim M, Jungbluth H
Paediatr Drugs. 2024; 26(6):719-740.
PMID: 39198371
DOI: 10.1007/s40272-024-00649-3.
Bus S, de Haan R, Vermeulen M, van Schaik I, Eftimov F
Cochrane Database Syst Rev. 2024; 2:CD001797.
PMID: 38353301
PMC: 10865446.
DOI: 10.1002/14651858.CD001797.pub4.
Manganotti P, Garascia G, Furlanis G, Buoite Stella A
Front Neurosci. 2023; 17:1159929.
PMID: 37179564
PMC: 10166837.
DOI: 10.3389/fnins.2023.1159929.
Tonkin R, Ladha M, Johnson N, Astle W, Britton A, Shear N
SAGE Open Med Case Rep. 2022; 10:2050313X221117887.
PMID: 36003890
PMC: 9393491.
DOI: 10.1177/2050313X221117887.
Koneczny I, Tzartos J, Mane-Damas M, Yilmaz V, Huijbers M, Lazaridis K
Front Immunol. 2022; 13:834342.
PMID: 35401530
PMC: 8986991.
DOI: 10.3389/fimmu.2022.834342.
Immunoglobulin for multifocal motor neuropathy.
Keddie S, Eftimov F, van den Berg L, Brassington R, de Haan R, van Schaik I
Cochrane Database Syst Rev. 2022; 1:CD004429.
PMID: 35015296
PMC: 8751207.
DOI: 10.1002/14651858.CD004429.pub3.
Neonatal Fc Receptor-Targeted Therapies in Neurology.
Nelke C, Spatola M, Schroeter C, Wiendl H, Lunemann J
Neurotherapeutics. 2022; 19(3):729-740.
PMID: 34997443
PMC: 9294083.
DOI: 10.1007/s13311-021-01175-7.
IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti-B Cell Therapies.
Dalakas M
Neurol Neuroimmunol Neuroinflamm. 2021; 9(1).
PMID: 34845096
PMC: 8630661.
DOI: 10.1212/NXI.0000000000001116.
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy.
Dalakas M
Neurotherapeutics. 2021; 18(4):2397-2418.
PMID: 34766257
PMC: 8585501.
DOI: 10.1007/s13311-021-01108-4.
Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 - A theoretical perspective.
Yaqinuddin A, Ambia A, Elgazzar T, AlSaud M, Kashir J
Med Hypotheses. 2021; 151:110592.
PMID: 33878626
PMC: 8032597.
DOI: 10.1016/j.mehy.2021.110592.
Off-Label Use of Intravenous Immunoglobulin with Methylprednisolone to Treat Parsonage-Turner Syndrome in a United States Marine.
Sedlacek C, Leone M, Foster A, Hinkelman A
Case Rep Med. 2021; 2021:6663755.
PMID: 33868407
PMC: 8035001.
DOI: 10.1155/2021/6663755.
Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg.
Beydoun S, Sharma K, Bassam B, Pulley M, Shije J, Kafal A
Front Neurol. 2021; 12:638816.
PMID: 33763019
PMC: 7982536.
DOI: 10.3389/fneur.2021.638816.
The importance of FcRn in neuro-immunotherapies: From IgG catabolism, gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors.
Dalakas M, Spaeth P
Ther Adv Neurol Disord. 2021; 14:1756286421997381.
PMID: 33717213
PMC: 7917847.
DOI: 10.1177/1756286421997381.
Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K, Brusse E, Jacobs B, Vrancken A, Eftimov F, Notermans N
Eur J Neurol. 2020; 28(1):286-296.
PMID: 32876962
PMC: 7820989.
DOI: 10.1111/ene.14501.
New Therapeutic Horizons for Graves' Hyperthyroidism.
Lane L, Cheetham T, Perros P, Pearce S
Endocr Rev. 2020; 41(6).
PMID: 32845332
PMC: 7567404.
DOI: 10.1210/endrev/bnaa022.
Engineering of Fc Multimers as a Protein Therapy for Autoimmune Disease.
Fitzpatrick E, Wang J, Strome S
Front Immunol. 2020; 11:496.
PMID: 32269572
PMC: 7109252.
DOI: 10.3389/fimmu.2020.00496.
Plasmapheresis for the Treatment of Anti-M Alloimmunization in Pregnancy.
Maki Y, Ushijima J, Furukawa S, Inagaki H, Takenouchi H, Fujimoto S
Case Rep Obstet Gynecol. 2020; 2020:9283438.
PMID: 32089921
PMC: 7029308.
DOI: 10.1155/2020/9283438.
Autoantibodies in Neuropsychiatric Disorders.
Hoffmann C, Zong S, Mane-Damas M, Molenaar P, Losen M, Martinez-Martinez P
Antibodies (Basel). 2019; 5(2).
PMID: 31557990
PMC: 6698850.
DOI: 10.3390/antib5020009.
Intravenous Immunoglobulin Treatment for Recurrent Optic Neuritis.
Altunrende B, Akdal G, Soylev Bajin M, Yaman A, Kocaslan M, Nalbantoglu M
Noro Psikiyatr Ars. 2019; 56(1):3-6.
PMID: 30911229
PMC: 6427084.
DOI: 10.5152/npa.2017.20577.
Efficacy of Antenatal Intravenous Immunoglobulin Treatment in Pregnancies at High Risk due to Alloimmunization to Red Blood Cells.
Mayer B, Hinkson L, Hillebrand W, Henrich W, Salama A
Transfus Med Hemother. 2018; 45(6):429-436.
PMID: 30574060
PMC: 6288630.
DOI: 10.1159/000490154.
